199 related articles for article (PubMed ID: 10777608)
1. Communication between the ATPase and cleavage/religation domains of human topoisomerase IIalpha.
Bjergbaek L; Kingma P; Nielsen IS; Wang Y; Westergaard O; Osheroff N; Andersen AH
J Biol Chem; 2000 Apr; 275(17):13041-8. PubMed ID: 10777608
[TBL] [Abstract][Full Text] [Related]
2. Hindering the strand passage reaction of human topoisomerase IIalpha without disturbing DNA cleavage, ATP hydrolysis, or the operation of the N-terminal clamp.
Oestergaard VH; Giangiacomo L; Bjergbaek L; Knudsen BR; Andersen AH
J Biol Chem; 2004 Jul; 279(27):28093-9. PubMed ID: 15123700
[TBL] [Abstract][Full Text] [Related]
3. Probing the interaction of the cytotoxic bisdioxopiperazine ICRF-193 with the closed enzyme clamp of human topoisomerase IIalpha.
Patel S; Jazrawi E; Creighton AM; Austin CA; Fisher LM
Mol Pharmacol; 2000 Sep; 58(3):560-8. PubMed ID: 10953049
[TBL] [Abstract][Full Text] [Related]
4. The QTK loop is essential for the communication between the N-terminal atpase domain and the central cleavage--ligation region in human topoisomerase IIalpha.
Bendsen S; Oestergaard VH; Skouboe C; Brinch M; Knudsen BR; Andersen AH
Biochemistry; 2009 Jul; 48(27):6508-15. PubMed ID: 19485418
[TBL] [Abstract][Full Text] [Related]
5. Characterisation of the DNA-dependent ATPase activity of human DNA topoisomerase IIbeta: mutation of Ser165 in the ATPase domain reduces the ATPase activity and abolishes the in vivo complementation ability.
West KL; Turnbull RM; Willmore E; Lakey JH; Austin CA
Nucleic Acids Res; 2002 Dec; 30(24):5416-24. PubMed ID: 12490710
[TBL] [Abstract][Full Text] [Related]
6. DNA cleavage and religation by human topoisomerase II alpha at high temperature.
Bromberg KD; Osheroff N
Biochemistry; 2001 Jul; 40(28):8410-8. PubMed ID: 11444988
[TBL] [Abstract][Full Text] [Related]
7. The p53 tumor suppressor stimulates the catalytic activity of human topoisomerase IIalpha by enhancing the rate of ATP hydrolysis.
Kwon Y; Shin BS; Chung IK
J Biol Chem; 2000 Jun; 275(24):18503-10. PubMed ID: 10764786
[TBL] [Abstract][Full Text] [Related]
8. The transducer domain is important for clamp operation in human DNA topoisomerase IIalpha.
Oestergaard VH; Bjergbaek L; Skouboe C; Giangiacomo L; Knudsen BR; Andersen AH
J Biol Chem; 2004 Jan; 279(3):1684-91. PubMed ID: 14583603
[TBL] [Abstract][Full Text] [Related]
9. The DNA dependence of the ATPase activity of human DNA topoisomerase IIalpha.
Hammonds TR; Maxwell A
J Biol Chem; 1997 Dec; 272(51):32696-703. PubMed ID: 9405488
[TBL] [Abstract][Full Text] [Related]
10. The N-terminal domain of human topoisomerase IIalpha is a DNA-dependent ATPase.
Gardiner LP; Roper DI; Hammonds TR; Maxwell A
Biochemistry; 1998 Dec; 37(48):16997-7004. PubMed ID: 9836594
[TBL] [Abstract][Full Text] [Related]
11. Mutagenesis of E477 or K505 in the B' domain of human topoisomerase II beta increases the requirement for magnesium ions during strand passage.
West KL; Meczes EL; Thorn R; Turnbull RM; Marshall R; Austin CA
Biochemistry; 2000 Feb; 39(6):1223-33. PubMed ID: 10684600
[TBL] [Abstract][Full Text] [Related]
12. A human topoisomerase II alpha heterodimer with only one ATP binding site can go through successive catalytic cycles.
Skouboe C; Bjergbaek L; Oestergaard VH; Larsen MK; Knudsen BR; Andersen AH
J Biol Chem; 2003 Feb; 278(8):5768-74. PubMed ID: 12480934
[TBL] [Abstract][Full Text] [Related]
13. Stability of the topoisomerase II closed clamp conformation may influence DNA-stimulated ATP hydrolysis.
Vaughn J; Huang S; Wessel I; Sorensen TK; Hsieh T; Jensen LH; Jensen PB; Sehested M; Nitiss JL
J Biol Chem; 2005 Mar; 280(12):11920-9. PubMed ID: 15647268
[TBL] [Abstract][Full Text] [Related]
14. Catalysis of ATP hydrolysis by two NH(2)-terminal fragments of yeast DNA topoisomerase II.
Olland S; Wang JC
J Biol Chem; 1999 Jul; 274(31):21688-94. PubMed ID: 10419479
[TBL] [Abstract][Full Text] [Related]
15. gyrB-225, a mutation of DNA gyrase that compensates for topoisomerase I deficiency: investigation of its low activity and quinolone hypersensitivity.
Heddle JG; Lu T; Zhao X; Drlica K; Maxwell A
J Mol Biol; 2001 Jun; 309(5):1219-31. PubMed ID: 11399091
[TBL] [Abstract][Full Text] [Related]
16. Analysis of etoposide binding to subdomains of human DNA topoisomerase II alpha in the absence of DNA.
Leroy D; Kajava AV; Frei C; Gasser SM
Biochemistry; 2001 Feb; 40(6):1624-34. PubMed ID: 11327821
[TBL] [Abstract][Full Text] [Related]
17. Mutation of cysteine residue 455 to alanine in human topoisomerase IIalpha confers hypersensitivity to quinones: enhancing DNA scission by closing the N-terminal protein gate.
Bender RP; Osheroff N
Chem Res Toxicol; 2007 Jun; 20(6):975-81. PubMed ID: 17516663
[TBL] [Abstract][Full Text] [Related]
18. DNA topoisomerases as targets for the anticancer drug TAS-103: DNA interactions and topoisomerase catalytic inhibition.
Fortune JM; Velea L; Graves DE; Utsugi T; Yamada Y; Osheroff N
Biochemistry; 1999 Nov; 38(47):15580-6. PubMed ID: 10569942
[TBL] [Abstract][Full Text] [Related]
19. Investigating the role of the latch in the positive supercoiling mechanism of reverse gyrase.
RodrÃguez AC
Biochemistry; 2003 May; 42(20):5993-6004. PubMed ID: 12755601
[TBL] [Abstract][Full Text] [Related]
20. Interdomain communication in DNA topoisomerase II. DNA binding and enzyme activation.
Mueller-Planitz F; Herschlag D
J Biol Chem; 2006 Aug; 281(33):23395-404. PubMed ID: 16782968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]